[Effectiveness of therapy of endometriosis with danazol and chlormadinone acetate and their effect on paraclinical parameters].
article
OA: closed
CC0
AI-generated summary
Danazol and chlormadinone acetate both reduced endometriosis symptoms in women, with danazol causing more significant metabolic changes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The effect of danazol in a dose of 400 mg-800 mg per day for 6 month was studied in 10 women and also chlormadinone acetate 2 X 2 mg per day. Clinical investigation and laboratory test were done before the therapy has been started, during treatment (after the 2 and the 6 month) and 2 month after the end of therapy. Two month after discontinuation of danazol 5 women were free of symptoms. The metabolic studies revealed significant changes in many biochemical parameters. Two month after discontinuation of chlormadinone acetate also 5 women were free of symptoms. The metabolic studies revealed significant changes only for the blood plateled concentration and serum bilirubin.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-08-21T06:14:13.963979+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:40.384591+00:00
License: CC0
· commercial use OK